Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+145.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+145.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
14.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$184.42M+404.5%
2024$36.55M+316.3%
2023$8.78M-29.2%
2022$12.40M-
2021$0.00-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-